The PROSECCA Study, Answering New Questions in Prostate Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Nearly half of all cancer patients receive radiotherapy as part of their treatment and although it is effective at destroying cancerous lesions deep within the body, this comes at the cost of damaging healthy, or normal, tissues. With 50% of cancer patients surviving for 10 years or more, these patients can be left with life-changing side effects from their radiotherapy. It is clear that more must be done to limit damage to normal healthy tissue without compromising annihilation of the tumour and curing patients. The key to this is personalising an individual's radiotherapy treatment, in other words rather than assuming that all tumours respond similarly to radiotherapy, the treatment is optimised for an individual. To date, approaches to do this have been restricted to small numbers of carefully selected patients, are inordinately expensive, and not suitable for rolling out into everyday practice across the NHS. There is however another way, namely using Artificial Intelligence (AI) combined with an individual's healthcare record. By linking together large numbers of healthcare records at a national level, combined with the power of AI, the PROSECCA project will transform radiotherapy and cancer care.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Leczenie za pomocą radioterapii wiązką zewnętrzną (aparat zwany akceleratorem liniowym)
- •Regularnie wykonywane badania PSA (markera prostaty) po radioterapii
- •Co najmniej 10 lat przeżycia po radioterapii
- •Dostępne zdjęcia tomografii komputerowej (CT) w celu diagnostyki
- •Dostępne plany radioterapii z tomografii komputerowej
- •Dostępne dane z planowania leczenia
- •Dostępne zapisy z historii medycznej do oceny skutków ubocznych
✗ Disqualifies
- •Niedokończony kurs radioterapii
- •Brak danych PSA
- •Brak dostępnych danych z wizyt kontrolnych
- •Brak dostępnych zdjęć medycznych
Simplified criteria — AI translation
Trial details
- Last updated (source)
- August 26, 2026
- Sex
- Male only
Locations (1)
University of Edinburgh
Edinburgh, United Kingdom
Trial contact
Bill Nailon
Duncan McLaren
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/27/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.